Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0UO4B
|
||||
Former ID |
DNCL001590
|
||||
Drug Name |
RQ-00000005
|
||||
Synonyms |
Capromorelin
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Frailty [ICD10:R54] | Phase 2 | [522109] | ||
Company |
RaQualia Pharma
|
||||
Structure |
Download2D MOL |
||||
Formula |
C28H35N5O4
|
||||
Canonical SMILES |
CC(C)(C(=O)NC(COCC1=CC=CC=C1)C(=O)N2CCC3=NN(C(=O)C3(C2)<br />CC4=CC=CC=C4)C)N
|
||||
InChI |
1S/C28H35N5O4/c1-27(2,29)25(35)30-22(18-37-17-21-12-8-5-9-13-21)24(34)33-15-14-23-28(19-33,26(36)32(3)31-23)16-20-10-6-4-7-11-20/h4-13,22H,14-19,29H2,1-3H3,(H,30,35)/t22-,28-/m1/s1
|
||||
InChIKey |
KVLLHLWBPNCVNR-SKCUWOTOSA-N
|
||||
CAS Number |
CAS 193273-66-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Growth hormone secretagogue receptor type 1 | Target Info | Agonist | [532719] | |
NetPath Pathway | Leptin Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.